GnRh Antagonists
Para leerlo en español, clic aquí.
Remember, the information on my website, podcast, Instagram, and any other ways I communicate and/or produce content is educational information only and not medical advice. Always check with your qualified medical professional before making any changes to your treatment plan for endometriosis or any other health problems. See my full disclaimer here.
Names of GnRh antagonists
Some new medications have been introduced onto the market in the past few years:
- 2018 – Orilissa by Abbvie: generic name elagolix
- 2022 – MyFembree / Ryeqo by Myovant/Pfizer: generic name relugolix (this also has “add back therapy” in the form of estradiol and norethindrone acetate)
- 2022 – Yselty by ObsEva: generic name linzagolix
Important: this page is about GnRh antagonists. This is not the same as GnRh agonists, like Lupron, Zoladex, Synarel, Prostrap, etc.
GnRh antagonists are symptom management only
GnRh antagonists are pills that lower estrogen by affecting the way your brain talks to your ovaries on the hypothalamus – pituitary – gonadal axis. The medications block the production of ovarian-stimulating hormones by competitively binding to the GnRh receptors. The medications block the receptor, therefore “competing” with the natural GnRh so it cannot bind with the receptor as it normally would. In turn, this reduces the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), therefore reducing estrogen and progesterone. However, endometriosis can continue making its own estrogen locally via the aromatase enzyme, which makes estrogen a different way than the ovaries do.
GnRh drugs are commonly prescribed by misinformed doctors as a treatment for endometriosis. However, they cannot diagnose, treat, remove, or shrink endometriosis lesions. What they may do is provide symptom management only (although many patients find the drug side effects intolerable).
GnRh antagonists can have serious side effects
On the prescribing information (and official website) for GnRh antagonists, there’s typically a long list of potential side effects including suicidal thoughts or actions, bone mineral density loss, abnormal liver scans, hot flashes and night sweats, headache, nausea, difficulty sleeping, absence of periods, anxiety, joint pain, depression, and mood changes.
Orilissa has been approved by the FDA for the management of endometriosis symptoms for 6 months on the higher dose and 2 years on the lower dose. Myfembree and Ryeqo are also only approved for 2 years. This is due to the risk for bone loss on this drugs. You should speak to your doctor about having a bone density scan to periodically check your bone density.
In summary and more information
GnRh medications are not your only option. See my GnRh summary.
Resources
For More Info
- Endometriosis: Report-at-a-Glance – Report on Orilissa by ICER. “The Institute for Clinical and Economic Review (ICER) is an independent nonprofit research institute that produces reports analyzing the evidence on the effectiveness and value of drugs and other medical services.”
- Elagolix for endometriosis: all that glitters is not gold. Paolo Vercellini, Paola Viganò, Giussy Barbara, Laura Buggio, Edgardo Somigliana, ‘Luigi Mangiagalli’ Endometriosis Study Group, Human Reproduction, Volume 34, Issue 2, February 2019, Pages 193–199, https://doi.org/10.1093/humrep/dey368
Related Podcast Episodes
- Ep 30 – Orilissa and Lupron. Part 1 – Misconceptions and Marketing
- Ep 31 – Orilissa and Lupron. Part 2A – How Effective is Orilissa?
- Ep 37 – Orilissa and Lupron. Part 3 – Side Effects
- Ep 91 – What Can Hormonal Suppression Actually Do For Endometriosis?
- Ep 92 – Hormonal Medication Options for Endometriosis